Market Overview

Bone infection also called as Osteomyelitis is rare disease which can spread through various means such as blood stream, exposure of bone to infectious environment after surgery or injury. Staphylococcus aureus is known type of bacteria to infect the bone. Conditions such as diabetes in which wound takes time to heal is reported increases the chances of bone infection.

Bone infection can affect any age group and it is specially observed more in people with compromised immune system such as people with diabetes, HIV, sickle cell disease, rheumatoid arthritis, hemodialysis, etc. The incidence of the bone infection is low, as per CDC the incidence of the bone infection in the U.S. is around 2 in every 10,000 people.

Increasing prevalence of the diseases such as diabetes, rheumatoid arthritis, etc. which increases risk of bone infection is expected to drive the growth of the bone infection treatment market. Increasing availability of treatment options expected to increase traction for bone infection treatment market growth. Increasing R & D expenditure by pharmaceutical and biopharmaceutical companies for developing novel therapy for the bone infection treatment further expected to fuel the growth of the bone infection treatment market. Favorable drug development and approval approach by the regulatory authorities expected to increase the number of molecules in the pipeline for the bone infection treatment which in turn expected to drive the growth of the bone infection treatment market.

The fast tract approval and orphan drug status offered by regulatory authorities inspires the manufacturers to further increase their R & D investment, in turn driving the growth of the bone infection treatment market. Increasing global ageing population expected to further drive the growth of the bone infection treatment market.

Increasing awareness about the available options for the bone infection treatment expected to drive the growth of the bone infection treatment market. Whereas, currently limited options available for the bone infection treatment may hamper the potential growth of the bone infection treatment market.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation

Drug Type	Penicillin Cephalosporin Aminoglycosides Tetracycline Others
oute of administration	Oral Topical Injectable
distribution channel	Hospital Pharmacies Retail Pharmacies Dermatology Clinics Online Pharmacies
Region	North America Latin America Europe Asia Pacific Middle East & Africa